Abstract
Osteoclasts are known to be formed by fusion of circulating mononuclear precursor cells which originate from haematopoietic stem cells. The precise mechanisms regulating the cell-cell fusion of these circulating cells to multinucleated osteoclasts remain unclear. In the present study, human peripheral blood mononuclear cells (PBMNCs) from healthy donors were treated with the macrophagecolony stimulating factor (M-CSF) and receptor activator of nuclear factor (NF)-κB ligand (RANKL) to induce osteoclast differentiation. Osteoclast formation and resorption activity were investigated through the use of tartrate-resistant acid phosphatase (TRAP) staining and lacunar resorption on dentine slices respectively. Real-time reverse-transcription polymerase chain reaction (PCR) was used to detect expression of dendritic cell-specific transmembrane protein (DC-STAMP) in these cells. The results showed that under the treatment of M-CSF and RANKL, PBMNCs differentiated into multinucleated osteoclasts through cell-cell fusion of mononucleated cells. These osteoclasts were TRAP positive and capable of resorbing the bone. Expression of DC-STAMP was much higher in the cells treated with both M-CSF and RANKL than those treated with M-CSF alone. We concluded that human PBMNCs might differentiate into active osteoclasts under certain conditions and the DC-STAMP, which is believed critical for osteoclast development, will be a possible therapeutic target for osteoclast related diseases in future.
[1] Fujikawa Y., Quinn J.M., Sabokbar A., McGee J.O., Athanasou N.A., The human osteoclast precursor circulates in the monocyte fraction, Endocrinology, 1996, 137, 4058–4060 http://dx.doi.org/10.1210/en.137.9.405810.1210/endo.137.9.8756585Search in Google Scholar PubMed
[2] Boyle W.J., Simonet W.S., Lacey D.L., Osteoclast differentiation and activation, Nature, 2003, 423, 337–342 http://dx.doi.org/10.1038/nature0165810.1038/nature01658Search in Google Scholar PubMed
[3] Kukita T., Wada N., Kukita A., Kakimoto T., Sandra F., Toh K., et al., RANKL-induced DC-STAMP is essential for osteoclastogenesis, J. Exp. Med., 2004, 200, 941–946 http://dx.doi.org/10.1084/jem.2004051810.1084/jem.20040518Search in Google Scholar PubMed PubMed Central
[4] Ishii M., Saeki Y., Osteoclast cell fusion: mechanisms and molecules, Mod. Rheumatol., 2008, 18, 220–227 http://dx.doi.org/10.1007/s10165-008-0051-210.1007/s10165-008-0051-2Search in Google Scholar PubMed
[5] Livak K.J., Schmittgen T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 2001, 25, 402–408 http://dx.doi.org/10.1006/meth.2001.126210.1006/meth.2001.1262Search in Google Scholar PubMed
[6] Kreja L., Liedert A., Schmidt C., Claes L., Ignatius A., Influence of receptor activator of nuclear factor (NF)-kappaB ligand (RANKL), macrophage-colony stimulating factor (M-CSF) and fetal calf serum on human osteoclast formation and activity, J. Mol. Histol., 2007, 38, 341–345 http://dx.doi.org/10.1007/s10735-007-9108-310.1007/s10735-007-9108-3Search in Google Scholar PubMed
[7] Husheem M., Nyman J.K., Vaaraniemi J., Vaananen H.K., Hentunen T.A., Characterization of circulating human osteoclast progenitors: development of in vitro resorption assay, Calcif. Tissue. Int., 2005, 76, 222–230 http://dx.doi.org/10.1007/s00223-004-0123-z10.1007/s00223-004-0123-zSearch in Google Scholar PubMed
[8] Hartgers F.C., Vissers J.L., Looman M.W., van Zoelen C., Huffine C., Figdor C.G., et al., DC-STAMP, a novel multimembrane-spanning molecule preferentially expressed by dendritic cells, Eur. J. Immunol. 2000, 30, 3585–3590 http://dx.doi.org/10.1002/1521-4141(200012)30:12<3585::AID-IMMU3585>3.0.CO;2-Y10.1002/1521-4141(200012)30:12<3585::AID-IMMU3585>3.0.CO;2-YSearch in Google Scholar
[9] Yagi M., Miyamoto T., Sawatani Y., Iwamoto K., Hosogane N., Fujita N., et al., DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells, J. Exp. Med., 2005, 202, 345–351 http://dx.doi.org/10.1084/jem.2005064510.1084/jem.20050645Search in Google Scholar
[10] Kim M.S., Day C.J., Morrison N.A., MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation, J. Biol. Chem., 2005, 280, 16163–16169 http://dx.doi.org/10.1074/jbc.M41271320010.1074/jbc.M412713200Search in Google Scholar
[11] Kyriakides T.R., Foster M.J., Keeney G.E., Tsai A., Giachelli C.M., Clark-Lewis I., et al., The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation, Am. J. Pathol., 2004, 165, 2157–2166 10.1016/S0002-9440(10)63265-8Search in Google Scholar PubMed PubMed Central
[12] Vignery A., Macrophage fusion: the making of osteoclasts and giant cells, J. Exp. Med., 2005, 202, 337–340 http://dx.doi.org/10.1084/jem.2005112310.1084/jem.20051123Search in Google Scholar PubMed PubMed Central
© 2009 Versita Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
